Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/sickle-cell-disease-and-hematopoietic-stem-cell-transplantation/descriptif_3836233
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3836233

0 article 

 Frais de port 0,01€*

Exclusivité web : à partir de 35 euros d’achat, frais de port à 1 centime pour les expéditions vers la France métropolitaine, la Suisse et l’UE avec Colissimo ou GLS

Sickle Cell Disease and Hematopoietic Stem Cell Transplantation , 1st ed. 2018

Langue : Anglais

Coordonnateurs : Meier Emily Riehm, Abraham Allistair, Fasano Ross M.

Couverture de l’ouvrage Sickle Cell Disease and Hematopoietic Stem Cell Transplantation
This book provides a comprehensive, state-of-the art review of hematopoietic stem cell transplantation (HSCT) for sickle cell disease (SCD).  The book reviews new data about risk prediction for severe SCD, outlines the unique challenges of  HSCT for patients with SCD, profiles the supportive care guidelines for patients who are undergoing HSCT, highlights our current understanding of the best transfusion support for SCD patients prior to, during and after HSCT, and provides new perspectives about the ethics of HSCT for pediatric patients with SCD. Published in the last few years, several landmark phase III trials that utilize matched unrelated and haploidentical donors for HSCT in SCD patients are also placed in context with respect to current management. 

Written by experts in the field, Sickle Cell Disease and Hematopoietic Stem Cell Transplantation is a valuable resource for physicians and researchers dealing with and interested in this challenging, yet exciting, curative therapy for sickle cell disease, that will help guide patient management and stimulate investigative efforts.

Part I Sickle Cell Disease

 

1. Clinical Manifestations of Sickle Cell Disease Across the Lifespan

Lydia H. Pecker, Jane Little

 

2. Pathobiology of Sickle Cell Disease Vaso-Occlusion and Targeted Therapies

Kerry A. Morrone, Jennifer Davila, W. Beau Mitchell, Deepa Manwani

 

3. Current Non-HSCT Related Treatments for SCD

Claire L. Anderson, Deepika S. Darbari

 

4. Risk Based Therapies for Sickle Cell Disease

Emily R. Meier

 

5. Transfusion Support of the Patient with Sickle Cell Disease Undergoing Transplantation

Jeanne E. Hendrickson, Ross M. Fasano

 

6. Neurological Manifestations of Sickle Cell Disease and Their Impact on Allogeneic Hematopoietic Stem Cell Transplantation

Jessica Carpenter, Monica L. Hulbert

 

Part II Hematopoietic  Stem Cell Transplantation

 

7. Overview of Hematopoietic Stem Cell Transplantation for Non-Malignant Diseases

Karen L Zimowski, Shanmuganathan Chandrakasan

 

8. Unique Challenges of Hematopoietic Stem Cell Transplant for Sickle Cell Disease

Pooja Khandelwal, Michael Grimley

 

9. The Ethics of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Robert Sheppard Nickel, Naynesh Kamani

 

10. Psychosocial Care and Education of Children with Sickle Cell Disease undergoing Hematopoietic Stem Cell Transplant and their Families

Steven J. Hardy, Jasmine Holt, Amanda L. Thompson

 

11. Long Term Effects of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Karim T. Sadak, Angela R. Smith, Monica Bhatia

 

12. Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Gregory M.T. Guilcher, John T. Horan

 

13. Unrelated Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Alexander Ngwube, Shalini Shenoy

 

14. Haploidentical Hematopoietic Cell Transplantation for Sickle Cell Disease

Elizabeth O. Stenger, Allistair Abraham


15. Gene Therapy 101: The Path Toward Becoming a Realistic Cure for Patients with Sickle Cell Disease

Alexis Leonard, Allistair Abraham

Emily Riehm Meier, MD, MSHS
Pediatric Hematologist and Director, Sickle Cell Research, Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA

Allistair Abraham, MD
Children’s National Medical Center, Division of Blood and Marrow Transplantation, Washington, DC, USA

Ross M. Fasano, MD
Emory University School of Medicine, Department of Pathology & Laboratory Medicine, Atlanta GA, USA

Outlines the unique challenges of HSCT and profiles supportive care guidelines for patients with SCD

Reviews several landmark phase III trials that utilize matched unrelated and haploidentical donors for HSCT in SCD patients

Written by experts in the field

Includes supplementary material: sn.pub/extras

Date de parution :

Ouvrage de 334 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

94,94 €

Ajouter au panier

Date de parution :

Ouvrage de 334 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

137,14 €

Ajouter au panier